This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): QGE-031
Description: QGE031 is an anti-immunoglobulin E antibody.
Deal Structure: QGE031 was licensed by Novartis from Tanox, a wholly owned subsidiary of Genentech (part of the Roche Group).
Partners: Roche Holding AG
Additional information available to subscribers only: